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Ran, the small, predominantly nuclear GTPase, has been implicated in the regulation of
a variety of cellular processes including cell cycle progression, nuclear-cytoplasmic
trafficking of RNA and protein, nuclear structure, and DNA synthesis. It is not known
whether Ran functions directly in each process or whether many of its roles may be
secondary to a direct role in only one, for example, nuclear protein import. To identify
biochemical links between Ran and its functional target(s), we have generated and
examined the properties of a putative Ran effector mutation, T42A-Ran. T42A-Ran binds
guanine nucleotides as well as wild-type Ran and responds as well as wild-type Ran to
GTP or GDP exchange stimulated by the Ran-specific guanine nucleotide exchange
factor, RCC1. T42A-RanzGDP also retains the ability to bind p10/NTF2, a component of
the nuclear import pathway. In contrast to wild-type Ran, T42A-RanzGTP binds very
weakly or not detectably to three proposed Ran effectors, Ran-binding protein 1
(RanBP1), Ran-binding protein 2 (RanBP2, a nucleoporin), and karyopherin b (a compo-
nent of the nuclear protein import pathway), and is not stimulated to hydrolyze bound
GTP by Ran GTPase-activating protein, RanGAP1. Also in contrast to wild-type Ran,
T42A-Ran does not stimulate nuclear protein import in a digitonin permeabilized cell
assay and also inhibits wild-type Ran function in this system. However, the T42A
mutation does not block the docking of karyophilic substrates at the nuclear pore. These
properties of T42A-Ran are consistent with its classification as an effector mutant and
define the exposed region of Ran containing the mutation as a probable effector loop.
INTRODUCTION
Like other proteins of the Ras family, Ran acts as a
molecular switch through a GTPase cycle (Rush et al.,
1996; Sazer, 1996). Ran binds GTP, catalyzes its slow
hydrolysis to GDP, and slowly exchanges the bound
GDP for free nucleotide, which in vivo is predomi-
nantly GTP. GTP hydrolysis and guanine nucleotide
exchange rates are each increased approximately
100,000-fold by accessory proteins (RanGAP1 and
RCC1, respectively) (Klebe et al., 1995). Human Ran
GTPase-activating protein, RanGAP11, has been puri-
fied to homogeneity, and human, mouse, budding
yeast (Saccharomyces cerevisiae), and fission yeast
(Schizosaccharomyces pombe) RanGAP1 genes have been
§ Corresponding author.
1 Abbreviations used: aa, amino acid; BSA, bovine serum albu-
min; DTT, dithiothreitol; GST, glutathione S-transferase;
His*Tag, histidine-tagged; MOPS, 3-N-morpholinopropane-sul-
fonic acid; NTF, nuclear transport factor; RanBD, Ran-binding
domain; RanGAP1, Ran GTPase-activating protein 1; RCC1, reg-
ulator of chromosome condensation 1; RT, room temperature.
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cloned. Ran-specific guanine nucleotide exchange fac-
tor, first identified genetically and named RCC1 (reg-
ulator of chromosome condensation-1), has also been
purified to homogeneity from human cells, and hu-
man, Xenopus, S. cerevisiae, and S. pombe genes encod-
ing it have been cloned (for review, see Avis and
Clarke, 1996; Dasso, 1993; Rush et al., 1996; Sazer,
1996). Given the low intrinsic rates of GTP hydrolysis
and GDP release by Ran, both the RanzGTP/RanzGDP
ratio and the rate of RanzGTP turnover in vivo are
likely to be determined largely by activities of Ran-
GAP1, RCC1, or other accessory proteins (Nehrbass
and Blobel, 1996; Rush et al., 1996; Sazer, 1996).
Mutations in Ran, RanGAP1, or RCC1 are associated
with defects in nuclear protein import, the synthesis,
processing, and export of nuclear RNA, cell cycle pro-
gression, DNA synthesis, the restoration of nuclear
structure after mitosis, and the maintenance of inter-
phase nuclear structure (for review, see Dasso, 1993;
Elliott et al., 1994; Moore and Blobel, 1994a; Melchior
and Gerace, 1995; Tartakoff and Schneiter, 1995; Avis
and Clarke, 1996; Rush et al., 1996; Sazer, 1996). These
findings raise two biochemical questions. What mech-
anism links the Ran GTPase cycle to its downstream
target(s)? Which of these targets are directly regulated
by the Ran GTPase cycle, and which are affected sec-
ondarily?
Two distinct mechanisms can couple GTPase
switches to their downstream targets. The first is ex-
emplified by the role of true Ras proteins in intracel-
lular signaling and the second by the role of Rab
proteins in vesicular sorting. In the Ras paradigm, the
GTP-bound form of the GTPase interacts with an ef-
fector molecule to activate the latter and stimulate a
process. The amount of stimulation depends on the
amount of GTPasezGTP complex. In the Rab para-
digm, stimulation requires GTP hydrolysis, suggest-
ing GTPase interaction with at least two different ef-
fectors, one specific for GTPasezGTP and the other for
GTPasezGDP. The amount of stimulation depends on
the turnover of the GTPasezGTP complex.
Nuclear protein import is the best characterized of
the cellular processes affected by the Ran GTPase cy-
cle. Import of proteins containing polybasic nuclear
localization signals occurs in two steps (Newmeyer
and Forbes, 1988; Richardson et al., 1988; Moore and
Blobel, 1994a; Melchior and Gerace, 1995). The first is
energy independent and involves docking of the
karyophilic protein to the nuclear pore complex. The
second is energy dependent and involves transport of
the protein through the pore. When mammalian cells
are treated with digitonin, their plasma membranes
become permeable and many endogenous cytoplas-
mic and nuclear macromolecules are lost, while nuclei
and most cytoskeletal structures remain intact. Nu-
clear protein import halts in such permeabilized cells,
but can be restored by addition of cytosolic proteins
and an energy source (Adam et al., 1990). Docking
requires karyopherin a (importin a), which is the re-
ceptor for the nuclear localization signal, and karyo-
pherin b (importin b), a factor that binds to both
karyopherin a and the nuclear pore. Addition of Ran
(Melchior et al., 1993; Moore and Blobel, 1993), a small
Ran-interacting protein named p10 [or nuclear trans-
port factor (NTF)1 2] (Moore and Blobel, 1994b; Pas-
chal and Gerace, 1995), and GTP is necessary and
sufficient for the import of proteins already docked at
the nuclear pore. Studies using permeabilized cells
and other systems have shown that Ran trapped in
either its GTP- or GDP-bound forms does not support
import and, in addition, inhibits import stimulated by
wild-type Ran (Melchior et al., 1993; Moore and Blobel,
1993; Tachibana et al., 1994; Corbett et al., 1995; Pala-
cios et al., 1996; Schlenstedt et al., 1995a). These data
suggest that Ran functions here by a Rab-like mecha-
nism.
Four putative Ran effector proteins, RanBP1,
RanBP2, karyopherin b, and p10, have been identified
and roles for all of them have been demonstrated in
nuclear import. RanBP2/Nup358 is a nuclear pore
protein that binds to RanzGTP but not to RanzGDP
(Wu et al., 1995; Yokoyama et al., 1995). It is located on
the cytosolic face of the pore, at positions similar to
those where Ran charged with nonhydrolyzable GTP
analogues accumulate in permeabilized cell nuclear
import assays, and to the positions where RanzGTP
binds when incubated with purified nuclear envelopes
(Melchior et al., 1995; Wu et al., 1995). RanBP2/Nup358
is the only known RanzGTP-binding protein in the
nuclear envelope (Melchior et al., 1995), and antibodies
directed against it inhibit nuclear protein import
(Yokoyama et al., 1995). RanzGTP also binds to karyo-
pherin b (Rexach and Blobel ,1995; Lounsbury et al.,
1996b) and to RanBP1 (see below), while RanzGDP
binds to p10 (Nehrbass and Blobel, 1996). RanzGDP
does not bind either karyopherin b or RanBP1, nor
does karyopherin b bind RanBP1. However, the three
proteins together form a stable ternary complex, de-
tected experimentally by the ability of RanBP1 to stim-
ulate the interaction between karyopherin b and
RanzGDP (Chi et al., 1996, 1997). RanBP1 also increases
the affinity of the interaction between RanzGTP and
karyopherin b (Lounsbury et al., 1996b; Chi et al., 1996,
1997). These findings have led to models in which the
interaction of Ran with nucleoporins, RanBP1, karyo-
pherin b, and p10 drives karyophilic proteins through
the nuclear pore (Chi et al., 1996, 1997; Koepp and
Silver, 1996; Lounsbury et al., 1996b; Nehrbass and
Blobel, 1996). Many of the other processes disrupted
by defects in the Ran GTPase cycle depend on the
timely delivery of proteins to the cell nucleus; there-
fore, effects on these processes could be secondary to
disruption of nuclear protein import.
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Additional studies of the fourth putative Ran effec-
tor, RanBP1, however, suggest that it may mediate
effects of the Ran GTPase cycle that are independent of
the cycle’s role in nuclear protein import. RanBP1 is a
small (203-aa residues in mice and humans), acidic,
predominantly cytosolic protein. It binds to RanzGTP.
Although it does not possess GAP or guanine nucle-
otide exchange factor activities, it interacts with Ran-
GAP1 in a yeast double-hybrid assay and stimulates
RanGAP activity in vitro (Coutavas et al., 1993;
Lounsbury et al., 1994; Beddow et al., 1995; Bischoff et
al., 1995; Ren et al., 1995). As noted above, it also
stimulates Ran-karyopherin b interactions. RanBP1 is
about one-fifth as abundant as Ran (2 3 106 copies of
RanBP1 and 107 copies of Ran per mammalian cell),
and it might serve as a Ran coregulator. These bio-
chemical studies have not identified a clear effector
role for RanBP1, but a mutant RanzGTP protein lack-
ing its six carboxyl-terminal amino acids loses the
ability to bind tightly to RanBP1, retains the ability to
bind karyopherin b and reconstitute nuclear protein
import in digitonin-permeabilized cells, but loses the
ability to perturb cell cycle progression in transfected
293/Tag cells (Ren et al., 1995; Lounsbury et al., 1996b;
Chi et al., 1997). These findings suggest that RanBP1
may be an effector that links the Ran GTPase cycle to
cellular targets independent of and in addition to nu-
clear protein import.
To better define the mechanisms of Ran’s interac-
tions with its putative effectors and regulators, we
constructed a missense mutant of Ran homologous to
the mutations of RAS residue 35 that disrupt interac-
tions of the latter protein with its GAP and effector
proteins (Bourne et al., 1991; Vojtek et al., 1993) and
characterized the interactions of the Ran missense mu-
tant protein with RanGAP1, RCC1, and the putative
Ran effector proteins. We also examined the ability of
this mutant to support and/or inhibit nuclear protein
import in digitonin-permeabilized cells.
MATERIALS AND METHODS
Glutathione S-transferase (GST) Fusion Proteins
Polymerase chain reaction- (PCR) generated fragments of mouse
RanBP1 and mouse RanGAP1 cDNAs with upstream EcoRI sites
and downstream XhoI sites added to the respective PCR primers
were cloned in-frame downstream of the GST coding domain of
pGEX5–1 (Pharmacia LKB Biotechnology, Piscataway, NJ). GST-
RanBP1 A (full-length RanBP1, aa 1–203), GST-RanBP1 B (aa 1–159),
and GST-RanBP1 D (aa 69–203) were generated by cloning these
portions of the coding region of a mouse RanBP1 cDNA (Coutavas
et al., 1993). Two GST-RanGAP1 clones were generated from a
mouse RanGAP1 cDNA (Ren et al., 1995): full-length (aa 1–589) and
c-del (aa 1- 358). GST and GST fusion proteins were expressed by
induction of transformed bacterial cultures with 0.1 mM isopropy-
lthio-b-d-galactoside and purified batchwise using glutathione-aga-
rose (Sigma Chemical Co., St. Louis, MO). Proteins were eluted with
5 mM reduced glutathione in 50 mM Tris-HCl (pH 8.0) and 0.1 mM
phenylmethylsulfonyl fluoride.
Site-directed Mutagenesis of Ran
nucleotide sequence encoding Ala at codon 42 of Ran was intro-
duced into human Ran cDNA cloned in M13 mp18 (Coutavas et al.,
1993; Ren et al., 1995) using an oligonucleotide with an A to G
transition mutation at the 10th position (59-TATGTAGCCGCCTT-
GGGTGTT-39) and the reagents and protocol of the Amersham Life
Sciences “Sculptor” in vitro mutagenesis system. The resulting mu-
tation was confirmed by sequence analysis.
Recombinant Ran Proteins
Wild-type and mutant Ran coding regions were cloned into pET9c
(Novagen, Madison, WI), and bacteria transformed with these con-
structs were grown, induced, and lysed as described previously
(Ren et al., 1995). To purify wild-type and T42A-Ran proteins, crude
cell lysate (40 ml) from 4 l of culture was subjected to ammonium
sulfate fractionation. The precipitate from a 30 to 55% ammonium
sulfate fraction was resuspended in 10 ml of 10 mM Tris (pH 8.0)/1
mM dithiothreitol (DTT)/1 mM GTP, and incubated for 5 min on
ice. The sample was adjusted to a volume of 400 ml in 10 mM Tris
(pH 8.0)/1 mM DTT/1 mM MgCl2 and concentrated to a volume of
50 ml using positive pressure in an Amicon concentrator cell with a
YM-10 membrane. The material was clarified by centrifugation,
applied to a MonoQ HR10/10 column (Pharmacia, Pistcataway, NJ)
and eluted with a linear gradient of 0–500 mM NaCl. Ran proteins
usually eluted at a concentration of approximately 250 mM NaCl.
Column fractions were assayed for Ran by SDS-PAGE. Ran-contain-
ing fractions were pooled and applied to a Superdex HR75 26/60
gel filtration column (Pharmacia) in 10 mM HEPES (pH 7.5)/160
mM potassium acetate/1 mM DTT/5 mM magnesium acetate and
eluted at 3.00 ml/min. Both wild-type and T42A-Ran proteins
eluted from this column as single peaks with the mobility of 25-kDa
globular proteins. Peak fractions were pooled and concentrated
with Amicon YM-10 Centricon units spun at 3000 3 g for 30 to 60
min at 4°C. The proteins, greater than 90% pure by SDS-PAGE, were
stored in aliquots (2–3 mg/ml) at 280°C. Protein concentrations
were determined with the Bradford method using the Bio-Rad
protein assay kit. To charge proteins, GTP or GDP was added to a
final concentration of 1 mM and EDTA to a final concentration of 5
mM. The mixture was incubated for 20 min at room temperature
(RT). MgCl2 was then added to a final concentration of 20 mM to
stabilize Ranznucleotide complexes.
Constructs of Ran proteins with N-terminal histidine-tagged
(His*Tag, Novagen) fusions (23 aa) were made by cloning the wild-
type, T42A, and GTPase defective (dm) (G19V, Q69L) forms of Ran
into the pET19b vector, with a cloning strategy similar to that
described for GST fusion proteins but with PCR primers generating
NdeI or BamHI cleavable sites. His*Tag fusion proteins were ex-
pressed by induction of transformed bacterial cultures with 1.0 mM
isopropylthio-b-d-galactoside and purified in a batchwise manner
using nickel resin and the reagents and protocol of the Novagen
pET System.
Other Recombinant Proteins
Proteins expressed from pET21B constructs encoding His*Tag fu-
sions of the first or fourth Ran-binding domains (RanBD1, aa 1152–
1321; RanBD4, aa 2892–3060) of RanBP2/Nup358 (Wu et al., 1995;
Yokoyama et al., 1995) were a gift from J. Wu (Laboratory of Cell
Biology, The Rockefeller University, New York, NY). His*Tag fu-
sions of human karyopherin a and rat karyopherin b were purified
as described by Schwoebel and Moore (manuscript in preparation),
as were untagged Xenopus RCC1 and untagged human p10 and
karyopherin b. E. coli expression vectors were obtained from the
following investigators: His*Tag rat karyopherin b (lacking its
amino terminal 12 residues) from A. Radu (The Rockefeller Univer-
sity) (Moroianu et al., 1995), full-length human karyopherin b from
D. Go¨rlich (University of Heidelberg, Heidelberg, Germany),
His*Tag human karyopherin a (clone hSRP1a) from A. Lamond
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(European Molecular Biology Laboratories, Heidelberg, Germany)
(Weis et al., 1995), human p10 (“pp15” expression clone) from U.
Grundmann (Behringwerke, Marburg, Germany) (Lehmeier and
Amann, 1992; Grundmann et al., 1988), and Xenopus RCC1 from T.
Nishimoto (Kyushu University, Fukuoka, Japan).
In Vitro Binding of Ran to RanBP1, RanBP2, and
Karyopherin b Assayed by Gel Transfer Ligand
Binding
Filter-binding analysis of interactions with Ran proteins was per-
formed as described by Lounsbury et al. (1994). Briefly, 1-mg sam-
ples of recombinant proteins to be tested for interaction with Ran
were electrophoresed in duplicate 12% SDS-PAGE gels. One gel was
stained with Coomassie blue to confirm that intact proteins were
present in the expected amounts. Proteins were transferred from the
other gel to a nitrocellulose membrane, immobilized, renatured for
2 h at 4°C in 20 mM 3-N-morpholinopropane-sulfonic acid (MOPS)
(pH 7.1)/100 mM sodium acetate/5 mM magnesium acetate/0.25%
Tween 20/0.5% bovine serum albumin (BSA)/5 mM DTT, and then
incubated for 30 min at RT in 20 mM MOPS (pH 7.1)/100 mM
potassium acetate/5 mM magnesium acetate/0.05% Tween 20/
0.5% BSA/5 mM DTT/100 mM GTP. The filters were equilibrated
briefly in the same buffer without GTP before the addition of Ran
protein.
Two to three micrograms of purified Ran protein (wild type or
T42A) were incubated with 10 mCi of [a-32P]GTP (3000 Ci/mmol,
Dupont/New England Nuclear, Boston, MA) in 20 ml of 10 mM
MOPS (pH 7.1)/1 mM EDTA/0.1% BSA for 15 min on ice. (In those
cases where the probe contained RanBP1 1 Ran, a twofold excess
(4–6 mg) of GST-RanBP1 was added to the solution before adding
the GTP.) The reaction was then adjusted to 5 mM magnesium
acetate in a final volume of 0.5 ml, and the excess GTP was removed
with Microcon-10 units (Amicon, Beverly, MA) spun at 10,000 3 g
for 10 min. Aliquots of the loaded proteins were counted in a
scintillation counter and equal counts of loaded proteins (about 5 3
106 cpm) were added to 15 ml of 20 mM MOPS (pH 7.1)/100 mM
potassium acetate/5 mM magnesium acetate/0.05% Tween 20/
0.5% BSA/5 mM DTT and incubated with replicate blots for 30 min
at RT. Filters were then washed five times at RT in the same buffer
and autoradiographed. Autoradiographs were digitized using a
XRS 12cx flatbed scanner connected to an Apple 8100 Macintosh
computer. Images were printed on a Tektronix Phaser 440 dye
sublimation printer.
In Vitro Binding of Ran to RanBP1 and
Karyopherin b Assayed by Dot Ligand Blotting
Dot ligand blotting was performed exactly as described for gel
transfer blotting except 0.4- to 1-mg samples of native (nondena-
tured) RanBP1 and karyopherin b, each in 300 ml of phosphate-
buffered saline, were spotted directly onto nitrocellulose, and the
2-h renaturation step was omitted. For experiments using labeled
RanzGDP as a probe, wild-type or T42A-Ran proteins were charged
with 40 mCi [b-35S]GDP (1250 Ci/mmol) (DuPont/New England
Nuclear) as described above for [a-32P]GTP, and autoradiography
was performed at RT without intensifying screens. Reconstruction
experiments in which equal cpm of [a-32P]GTPzRan and [b-
35S]GDPzRan were spotted and autoradiographed showed the 35S
signal to be one-fourth that of the 32P signal; therefore, autoradiog-
raphy times of 35S samples were increased appropriately.
In Vitro Binding of Ran to p10 Assayed by His*Tag
Resin Binding
Binding assays were performed using His*Tag fusion proteins im-
mobilized on Ni21 resin (Novagen). Either His*Tag-Ran or His*Tag-
T42A-Ran beads were washed two or three times with 10 volumes
of 13 phosphate-buffered saline and collected by centrifugation at
1000 3 g. Ran and T42A-Ran were then charged by addition of GTP
or GDP to a final concentration of 1 mM and of EDTA to a final
concentration of 5 mM and incubation for 20 min at RT. Protein-
nucleotide complexes were then stabilized by the addition of
Mg(OAc)2 to a final concentration of 20 mM. Unbound nucleotide
was removed by washing the beads with binding buffer (20 mM
HEPES, pH 6.8, 150 mM KOAc, 2 mM Mg(OAc)2, 2 mM DTT, 0.1%
Tween 20, 0.1% casamino acids) (Rexach and Blobel, 1995). Un-
charged Ran was prepared using the same procedure except for the
absence of added guanine nucleotide and a preliminary wash in the
absence of added Mg(OAc)2. Binding assays were carried out in
50-ml volumes of binding buffer containing 2.5 mM immobilized
fusion protein and 3 mM free p10 protein. Assay mixes were incu-
bated for 1.5 to 2 h at 4°C, and beads were collected by centrifuga-
tion (1000 3 g) for 2 min. The supernatant was removed (“un-
bound” fraction). Beads were washed two to three times in binding
buffer, collected by centrifugation (1000 3 g), and the bound fraction
was released by boiling in an equal volume of SDS-PAGE loading
buffer (100 mM Tris-HCl, pH 6.8, 200 mM DTT, 4% SDS, 0.2%
bromophenol blue, 20% glycerol). One-half of each “unbound” and
all of bound fraction were analyzed on 12–15% SDS-PAGE gels.
Proteins were visualized by immunoblotting using a polyclonal
rabbit anti-p10 primary antibody, a goat anti-rabbit secondary an-
tibody, and a chemiluminescent substrate kit (KPL).
GAP Assays
To measure GTP hydrolysis by wild-type Ran, T42A-Ran, or GT-
Pase defective dm-Ran, His*Tag fusion forms of these proteins were
immobilized on His*Bind Resin (Novagen). The immobilized pro-
teins were equilibrated in 20 mM Tris-HCl (pH 7.5)/50 mM NaCl/1
mM EDTA/10% glycerol by washing the resin three times in 10
volumes of buffer followed by brief centrifugation at 1000 3 g. The
resin was resuspended in 50–100 ml of the same buffer containing 20
mCi of [g-32P]GTP (6000 Ci/mmol, Dupont/New England Nuclear)
and incubated for 20 min at RT. GTP-loaded protein was stabilized
and excess labeled GTP was removed by washing the resin five
times in 20 mM Tris-HCl (pH 7.5)/50 mM NaCl/15 mM MgCl2
(GAP buffer). The resin was resuspended in GAP buffer so that 50-ml
aliquots contained loaded Ran at a concentration of 1 mM. Individ-
ual aliquots were incubated for up to 30 min at 30°C with 1–5 ml of
various GST fusion proteins. Reactions were terminated by the
addition of 1 ml of ice-cold GAP buffer and centrifugation. Super-
natant fractions, containing hydrolyzed radioactive label, were sub-
jected to scintillation counting. Pelleted resin fractions were washed
with an additional 1 ml of GAP buffer before recovery for scintilla-
tion counting. In each case, the amount of label remaining com-
plexed (bound) to Ran protein (resin fraction) was expressed as a
percentage of the total cpm recovered from the resin and superna-
tant fractions.
Nucleotide Exchange Assays
The exchange of labeled GTP or GDP for unlabeled GTP or GDP,
respectively, on wild type or T42A-Ran was also examined using
His*Tag fusion proteins. In this case proteins were charged with 20
mCi of [a-32P]GTP (3000 Ci/mmol) or 40 mCi of [b-35S]GDP (1250
Ci/mmol) (DuPont/New England Nuclear), and individual ali-
quots were incubated at 30°C with 1 mM unlabeled GTP or GDP, in
the presence or absence of 0.2 mM purified Xenopus RCC1. Condi-
tions and measurements of bound label were the same as described
for GAP assays. All exchange and GAP assays were performed a
minimum of three times, with essentially identical results.
Nuclear Import Assay
Protein import assays, in digitonin-permeabilized buffalo rat liver
cells, used rhodamine-labeled human serum albumin coupled to
nuclear localization sequence peptides as an import substrate and 1
G.A. Murphy et al.
Molecular Biology of the Cell2594
mM GTP as an energy source. Assays at 21°C were performed as
described previously (Moore and Blobel, 1993; Ren et al., 1995),
except that recombinant human p10 was used in place of purified
Xenopus p10, and in some cases recombinant full-length human
karyopherins a and b were used in place of Xenopus fraction A. For
assays at 4°C, import mixtures were prepared on ice in the cold
room and pipetted onto Parafilm-covered glass plates on ice. Cov-
erslips with permeabilized cells were then placed cell side down on
the import mixtures.
RESULTS
T42A Mutant Ran Protein (E1-Ran) Interacts
Weakly with RanBP1 and not Detectably with
RanBP2/Nup358 or Karyopherin b
Wild-type RanzGTP binds to RanBP1, RanBP2/
Nup358, and karyopherin b, but not to p10, while
wild-type RanzGDP binds to p10 and not to the other
three proteins. This selective binding to only one nu-
cleotide-charged form of Ran supports the classifica-
tion of these four proteins as Ran effectors. RAS pro-
teins with alanine substituted for threonine at residue
35 are not sensitive to GAP stimulation and bind
poorly to effector proteins (Bourne et al., 1991; Vojtek et
al., 1993). The homologous amino acid in Ran is the
threonine at residue 42. Both the RAS and the Ran
threonine residues are exposed at the surfaces of the
proteins on peptide loops near the bases of the pro-
teins’ GTP-binding sites (Scheffzek et al., 1995). To
determine whether the region of Ran homologous to
the effector binding loop of true RAS proteins is in-
deed involved in such interactions, we generated the
corresponding Ran mutation, T42A. We designate the
mutant protein E1-Ran.
When equal amounts of wild-type Ran and E1-Ran
were incubated with radiolabeled GTP or GDP, both
proteins were labeled to the same specific activity, and
the bound nucleotide was essentially equally well re-
tained by both proteins (Figures 4D and 5, below, and
our unpublished observations). However, in contrast
to wild-type RanzGTP, E1-RanzGTP bound weakly or
not detectably to RanBP1 and did not bind detectably
to RanBP2/Nup358 or to karyopherin b (Figures 1 and
2). Specifically, in ligand blot assays (Figure 1), E1-
RanzGTP bound reproducibly but extremely weakly to
full-length RanBP1 protein and to a RanBP1 deletion
fragment that interacted with wild-type Ran. In con-
trast, E1-Ran failed to interact detectably with RanBP1
in multiple yeast double-hybrid assays (our unpub-
lished observations).
No protein of the size of RanBP2/Nup358 could be
detected in ligand blots of HeLa cell extracts probed
with E1-RanzGTP, in contrast to replicate blots probed
with wild-type RanzGTP (our unpublished observa-
tions). To confirm that E1-Ran failed to interact detect-
ably with RanBP2/Nup358, ligand-binding assays
were carried out with recombinant proteins corre-
sponding to two of the four specific Ran-binding do-
mains of RanBP2/Nup358. Under conditions in which
wild-type Ran bound strongly to both fragments, E1-
Ran failed to bind detectably to either (Figure 1).
Also, in ligand-binding assays, RanzGTP but not
E1-RanzGTP bound to karyopherin b (Figure 2). These
assays were done in two ways. The first (Figure 2A)
was a gel transfer, in which denatured proteins were
renatured after filter immobilization, and the second
(Figure 2B) was a dot assay, in which native proteins
were applied directly to the filter. In the case of karyo-
pherin b, we have found the nondenaturing dot-blot-
ting procedure to be much more sensitive than gel
transfer, perhaps due to the inefficient renaturation of
this protein. As shown in Figure 2, wild-type RanzGTP
bound clearly to karyopherin b, and its binding was
further stimulated in the presence of RanBP1, as re-
ported previously (Lounsbury et al., 1996b; Chi et al.,
1996, 1997). In contrast, E1-RanzGTP, either alone or in
the presence of RanBP1, failed to bind to karyopherin
b. Also as reported previously, the binding of wild-
type RanzGTP to a truncated form of karyopherin b
(lacking its 12-amino terminal residues; abbreviated D
karyopherin b in Figure 2) was weak and, in some
circumstances, detectable only in the presence of
RanBP1. As expected, when wild type and E1-Ran
charged with [b-35S]GDP were used as probes (with-
out added RanBP1) in a series of dot-blotting experi-
Figure 1. Interaction of wild-type and E1-Ran with RanBP1 and
RanBP2/Nup358, assayed by ligand blotting. One-microgram sam-
ples of intact GST-RanBP1 A (full length, aa 1–203), GST-RanBP1
fragments B (aa 1–159) and D (aa 69–203), and 0.3-mg samples of
two His*Tag Ran-binding domain fragments from RanBP2/Nup358
(RanBD1 and RanBD4) were resolved by SDS-PAGE, transferred to
nitrocellulose, renatured in situ, and probed with wild type and
E1-Ran charged with [a-32P]GTP. Filters were subjected to autora-
diography for 6 h. Mobilities of size markers, in kDa, are indicated
on the left. GST-RanBP1 fragment D, which does not bind to wild-
type RanzGTP, was included as a negative control.
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ments identical to those shown in Figure 2, neither
protein bound detectably to either RanBP1 or karyo-
pherin b (our unpublished observations). The same
result was obtained when RanBP1 was added to the
probes even though, as noted previously, RanBP1 had
been reported to promote an interaction between
wild-type RanzGDP and full-length karyopherin b
(Chi et al., 1996, 1997). This discrepancy may reflect a
difference in assay conditions, but the fact that RanBP1
did stimulate significant binding between wild-type
RanzGTP and karyopherin b, but not between E1-
RanzGTP and karyopherin b (Figure 2B), supports the
conclusion that the E1-Ran–karyopherin b interaction
is defective under all conditions.
Because of the difficulty in our hands of detecting
p10-RanzGDP binding using filter-immobilized p10,
ligand-binding assays were not used to compare the
interactions of wild-type and E1-RanzGDP with p10.
Instead, fixed matrix assays were used, with
His*Tag-Ran fusion proteins. Under conditions in
which essentially nucleotide-free wild-type Ran
bound a barely detectable amount of p10, p10 was
bound significantly by both E1-RanzGDP and wild-
type RanzGDP. The amount of binding to E1-Ran
was between one-fifth and one-half that observed
with wild-type Ran. A representative experiment is
shown in Figure 3. In additional fixed matrix assays,
neither wild-type nor E1-RanzGTP interacted with
karyopherin a, as expected; and wild-type RanzGTP
Figure 2. Interaction of wild type
and E1-Ran with RanBP1 and
karyopherin b, assayed by ligand
blotting. (A) Gel transfer assay. A
0.5-mg sample of GST-RanBP1 and
1-mg samples of GST, karyopherin
b, and a truncated karyopherin b
lacking its amino terminal 12 res-
idues (D karyopherin b) were
resolved by SDS-PAGE, transferred
to nitrocellulose, renatured in situ,
and probed with wild-type
Ranz[a32P]GTP alone, wild-type
Ranz[a-32P]GTP 1 RanBP1, or E1-
Ranz[a-32P]GTP alone. Filters were
subjected to autoradiography for
3 h. Mobilities of size markers in
kDa are indicated on the left. The
duplicate Coomassie blue-stained
gel shows the relative intactness of
the karyopherin b preparations. (B)
Dot blot assay. One- or 0.4-mg sam-
ples of nondenatured GST-RanBP1,
GST, karyopherin b, and D karyo-
pherin b were spotted directly onto
nitrocellulose and probed with
wild type and E1-Ran charged with
[a-32P]GTP in the presence or ab-
sence of added RanBP1 as indicated
on the left. Filters were subjected to
autoradiography for 4 h. The 1-mg
and 0.4-mg labels on the right indi-
cate the protein content of the adja-
cent eight dots.
Figure 3. Interaction of wild-type and E1-Ran with p10, assayed
by His*Tag resin binding. His*Tag-wild-type Ran (predominantly
nucleotide free, see MATERIALS AND METHODS), His*Tag-wild-
type RanzGDP, and His*Tag-E1-RanzGDP, bound to Ni21 resin,
were incubated with p10, and the amounts of the latter bound to the
resin were determined as described in MATERIALS AND METH-
ODS. Mobility of a size marker is indicated on the left and mobility
of p10 on the right. B, bound p10; U, unbound p10.
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but not E1-RanzGTP, wild-type RanzGDP, or E1-
RanzGDP interacted directly with karyopherin b
(our unpublished observations).
Taken together, these findings support the classifi-
cation of E1-Ran as an effector mutant. Under a variety
of assay conditions, the ability of E1-Ran to interact
with RanBP1 is sharply reduced, and the mutant pro-
tein yields no detectable interactions with the possible
Ran effectors RanBP2/Nup358 and karyopherin b.
The effector mutant retains the ability to interact with
p10, albeit to a somewhat reduced extent.
RanGAP1 Does Not Stimulate GTP Hydrolysis by
E1-Ran
The low or undetectable interactions of E1-RanzGTP
with RanBP1, RanBP2/Nup358, and karyopherin b
suggested that E1-Ran might also not respond to Ran-
GAP1. To validate our GAP assay, we demonstrated
that a RanGAP1 fusion protein accelerated hydrolysis
of GTP bound to Ran. We then assessed the effects of
adding RanBP1 and/or deleting the carboxyl-terminal
231 aa of RanGAP1 (c-del RanGAP1). The deleted
amino acids included a highly acidic domain, residues
359–399, common to mammalian and yeast RanGAP
proteins, and a carboxyl-terminal region unique to
mammalian RanGAP. In multiple trials, fusion Ran
reproducibly catalyzed little or no GTP hydrolysis
either alone or in the presence of 5 mM GST or 0.5 mM
GST-RanBP1 (less than 10% of bound 32P released in
the course of a 30-min incubation, our unpublished
observations), but was stimulated to catalyze rapid
GTP hydrolysis in the presence of wild-type Ran-
GAP1 fusion protein and was stimulated partially in
the presence of c-del RanGAP1 fusion protein. A
typical result is shown in Figure 4A. Wild-type
RanBP1 fusion protein reproducibly interacted with
both wild-type RanGAP1 (Figure 4B) and c-del Ran-
GAP1 (Figure 4C) to augment Ran-catalyzed GTP
hydrolysis. c-del RanGAP1 also interacted with
RanBP1 in a yeast double-hybrid assay (our unpub-
lished observations).
In multiple trials, E1-Ran alone also catalyzed
little or no GTP hydrolysis, but, in contrast to wild-
type Ran, it showed no additional GTPase activity in
the presence of full-length or c-del RanGAP1 (Fig-
ure 4D). [The assay could not exclude the possibility
of low level (,10%) stimulation.] Additional con-
trols confirmed that GTPase-defective Ran was also
insensitive to RanGAP1 and that no guanine nucle-
otide exchange activity could be detected in any of
these assay mixtures (Coutavas et al., 1993, and our
unpublished observations). Thus, under conditions
where wild-type Ran responded strongly and spe-
cifically to RanGAP1 stimulation, E1-Ran showed
no detectable response.
RCC1 Stimulates Guanine Nucleotide Exchange by
E1-Ran
Both wild-type and E1-Ran fusion proteins interacted
weakly with RCC1 in fixed matrix and yeast double-
hybrid assays (our unpublished observations), sug-
gesting that RCC1 might stimulate normal guanine
nucleotide exchange by E1-Ran. To test this possibil-
ity, purified wild-type and E1-Ran proteins charged
with either [a-32P]GTP or [b-35S]GDP were incubated
with excess unlabeled GDP or GTP in the presence or
absence of purified RCC1 protein, and amounts of
radioactivity remaining protein bound were measured
as a function of time. The results of typical experi-
ments in which labeled GTP was exchanged for unla-
beled GDP and in which labeled GDP was exchanged
for unlabeled GTP are shown in Figure 5. In the ab-
sence of RCC1, neither mutant nor wild-type Ran
exchanged extensive amounts of bound for free nucle-
otide. In contrast, in the presence of RCC1, both pro-
teins underwent extensive exchange within 1 min.
Similar results were obtained in multiple trials and in
studies of labeled GTP, unlabeled GTP exchange (our
unpublished observations). These results indicate that
E1-Ran can retain bound guanine nucleotides approx-
imately as well as wild-type Ran (as measured by low
intrinsic rates of GTP and GDP release) and that
RCC1-stimulated guanine nucleotide exchange rates
for E1-Ran and wild-type Ran are similar. [The
slightly greater intrinsic [b-35S]GDP release rate, com-
pared with that of [a-32P]GTP (Figure 5), was ob-
served consistently in multiple experiments. It may be
a property of the sulfur derivative, as Ran would
ordinarily be expected to release GDP more slowly
than GTP (Klebe et al., 1995)].
E1-Ran Blocks Nuclear Protein Import in Digitonin-
permeabilized Cells
Nuclear protein import in digitonin-permeabilized
buffalo rat liver cells requires the addition of karyo-
pherin a, karyopherin b, p10, and Ran. The added Ran
protein is thought to bind and hydrolyze GTP and to
interact with RanBP2/Nup358, karyopherin b, and
p10 in the course of stimulating import. We hypothe-
sized that E1-Ran would not substitute for wild-type
Ran in such a reconstitution experiment. To test this
hypothesis, we used permeabilized cells supple-
mented with Xenopus fraction A (which contains kary-
pherins a and b), human recombinant p10, and 1 mM
GTP. A titration study with wild-type RanzGDP
showed that it promoted maximal nuclear protein im-
port when added at a concentration of 50 mg/ml (Fig-
ure 6A). A parallel titration with E1-RanzGDP yielded
no restoration of import. To test the possibility that
E1-Ran might also inhibit protein import reconstituted
by the addition of wild-type Ran, we added various
amounts of E1-RanzGDP to import assays reconsti-
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tuted with a constant amount of wild-type RanzGDP.
E1-Ran inhibited import nearly completely when
added at a concentration twice that of the wild-type
protein (Figure 6B).
Moreover, this inhibition appears to be specific for
active transport through the nuclear pore and not for
docking (Figure 7). E1-RanzGDP did not block docking
of the import substrate at either 4°C (where import is
inhibited by the low temperature) or at 21°C (the
standard import assay temperature).
Inhibition of Nuclear Protein Import by E1-Ran Can
Be Overcome by the Addition of Excess p10
Since E1-Ran interacts poorly with RanBP1, RanBP2/
Nup358, and karyopherin b, but does interact with
p10, we next hypothesized that inhibition of import by
E1-Ran might be due to inhibitory p10 trapping. To
test this hypothesis, we used permeabilized cells sup-
plemented with purified human recombinant karyo-
pherin a, karyopherin b, and p10 proteins, and with 1
mM GTP.
As shown in Figure 8,A and B, permeabilized cells
reconstituted with purified components behave essen-
tially the same as ones reconstituted with Xenopus
fraction A; E1-RanzGDP alone does not support im-
port, and E1-Ran inhibits import stimulated by wild-
type Ran. However, the E1-Ran inhibition can be over-
come by addition of excess p10 (Figure 8C). The E1-
Ran inhibition and p10 rescue experiments shown in
Figure 8, B and C, respectively, used 15 mg/ml wild-
type Ran. Repetition of the inhibition and rescue stud-
ies with 30 mg/ml wild-type Ran yielded qualitatively
Figure 4. Stimulation of GTP hydrolysis by wild-type Ran but not E1-Ran, by full-length and carboxyl-terminal-deleted (c-del) RanGAP1
proteins. Recombinant wild-type Ranz[g-32P]GTP (;1 mM) was incubated with GST-RanGAP1 (A, ;0.01 mM, E or GST-c-del RanGAP1 (0.15
mM, f), GST-RanGAP1 (B, ;0.01 mM) alone (f) or GST-RanGAP1 (;0.01 mM) plus GST-RanBP1 (0.5 mM, E), and GST-c-del RanGAP1 (C,
;0.15 mM) alone (f) or GST-c-del RanGAP1 (;0.15 mM) plus GST-RanBP1 (0.5 mM, E). (D) E1-Ranz[g-32P]GTP (;1 mM) was incubated with
either GST (5.0 mM, f), GST-RanGAP1 (;0.01 mM, ), or GST-c-del RanGAP1 (0.15 mM, E). At the indicated times, the percentage of 32P still
bound to Ran was determined (see MATERIALS AND METHODS).
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the same result, but with higher levels of E1-Ran and
p10 needed to yield inhibition and rescue. (Compare
also Figure 6B, where a higher level of E1-Ran is
required to yield inhibition of import in the presence
of 50 mg/ml wild-type Ran).
DISCUSSION
Diverse cellular processes are disrupted when the Ran
GTPase cycle is perturbed, but it remains unclear
which of these processes are normally directly regu-
lated by Ran, and which are only affected secondarily,
e.g., as a consequence of a failure in nuclear protein
import. As one means of addressing this issue, we and
others have constructed missense and deletion mu-
tants of Ran to identify regions involved in modulat-
ing one biological process but not another (Dasso et al.,
1994; Ren et al., 1995; Carey et al., 1996). These studies
have exploited the close structural homology between
Ran and RAS proteins (Scheffzek et al., 1995). Here, we
have identified a residue, threonine 42, whose struc-
tural homologue in RAS can be mutated to perturb the
Figure 5. Stimulation of nucleotide exchange on wild-type and
E1-Ran in the presence of RCC1. (A) Recombinant wild-type Ranz[a-
32P]GTP (;1 mM, E, F) or E1-Ranz[a-32P]GTP (;1 mM, M, f) pro-
teins were incubated in the presence (F, f) or absence (E, M) of 0.2
mM RCC1. All reactions contained 1 mM unlabeled GDP. At the
indicated times, the percentage of 32P still bound to Ran was deter-
mined (see MATERIALS AND METHODS). (B) Recombinant wild-
type Ranz[b-35S]GDP (;1 mM, E, F) or E1-Ranz[b35S]GDP (;1 mM,
M, f) proteins were incubated in the presence (F, f) or absence (E,
M) of 0.2 mM RCC1. All reactions contained 1 mM unlabeled GTP.
At the indicated times, the percentage of 35S still bound to Ran was
determined.
Figure 6. (A) Effects of wild-type and E1-RanzGDP on nuclear
protein import in digitonin-permeabilized buffalo rat liver cells.
Assays were carried out at 21°C as described in MATERIALS AND
METHODS on permeabilized cells supplemented with 1.4 mg/ml of
Xenopus fraction A (which contains karyopherin a and b), 1.5 mg/ml
of purified human nuclear import factor p10, the indicated concen-
trations of wild-type RanzGDP (f) or E1-RanzGDP (E), 5 mg/ml of
NLS-tagged, rhodamine-labeled human serum albumin, and 1 mM
GTP. Protein import was measured as mean nuclear fluorescence in
arbitrary units. (B) Inhibition of nuclear import by E1-Ran. Assays
were performed at 21°C, in the presence of 1.45 mg/ml Xenopus
fraction A, 1.5 mg/ml p10, 50 mg/ml wild-type RanzGDP, 1 mM
GTP, and the indicated concentrations of additional wild-type
RanzGDP (f) or E1-RanzGDP (E).
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latter protein’s interaction with effectors (Vojtek et al.,
1993) and generated a mutant Ran protein with ala-
nine substituted for this threonine (T42A).
The biochemical properties of T42A mutant Ran
protein are consistent with its classification as an ef-
fector mutant, and we have designated it Ran effector
mutant 1, E1-Ran. It appears to bind and exchange
GTP and GDP normally, has little or no detectable
intrinsic GTPase activity, and also catalyzes little or no
GTP hydrolysis in the presence of RanGAP1 (Figures
4 and 5). In vitro, the E1-RanzGTP complex interacts
specifically with RanBP1, but the interaction is ex-
tremely weak compared with that between wild-type
RanzGTP and RanBP1 (Figures 1 and 2). E1-Ran does
not interact with RanBP1 in a double-hybrid assay.
The E1-RanzGTP complex also fails to interact with
karyopherin b or RanBP2/Nup358 (Figures 1 and 2).
Except for its ability to exchange GTP and GDP nor-
mally, these properties of E1-Ran are essentially the
same as those observed for another putative effector
mutant, L43E Ran (Lounsbury et al., 1996a).
RanBP1, RanBP2/Nup358, and karyopherin b bind
directly to RanzGTP but not RanzGDP, and, at least in
the cases of RanBP1 and RanBP2, a conserved amino
acid sequence motif, the so-called Ran-binding do-
main, mediates interactions with Ran (Butler and
Wolfe 1994; Beddow et al., 1995; Ouspenski et al., 1995;
Wu et al., 1995; Yokoyama et al., 1995; Dingwall et al.,
1996; Hartmann and Go¨rlich, 1995). Inasmuch as
RanBP2/Nup358 and karyopherin b have well-de-
fined roles in nuclear protein import and a budding
yeast strain mutant in a RanBP1 homologous gene
expresses defects in nuclear RNA and protein traffick-
ing (Schlenstedt et al. 1995b), it seems appropriate to
Figure 7. Effect of E1-Ran on docking of import substrate at the nuclear pore. Permeabilized cells were incubated with complete import
mixture (Mix) (karyopherins a and b (Xenopus fraction A), p10, 50 mg/ml wild-type RanzGDP, and 1 mM GTP) plus an additional 100 mg/ml
wild-type RanzGDP or 100 mg/ml E1-RanzGDP. Assays were performed at 21°C or at 4°C as described in MATERIALS AND METHODS.
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classify RanBP1, RanBP2/Nup358, and karyopherin b
as putative effectors and E1-Ran as an effector mutant.
The ability of the protein import factor p10 to bind
both His*Tag wild-type RanzGDP and His*Tag E1-
RanzGDP (Figure 3) suggests that p10 may interact
with a different region of Ran.
Amino acid residue 42 is located on a polypeptide
loop exposed at the surface of the Ran protein, hence
readily accessible for interactions with other proteins
(Scheffzek et al., 1995). The binding properties of the
T42A Ran mutant strongly suggest that this “E1 loop”
represents a major interacting domain, especially in
regard to several well-characterized proteins that link
the Ran GTPase cycle to nuclear protein import.
It was therefore not surprising to find that E1-Ran
did not support nuclear protein import in a digitonin
permeabilized cell assay (Figures 6–8). However, the
fact that E1-Ran inhibited import stimulated by wild-
type Ran was unexpected (Figures 6–8). Other mu-
tants of Ran trapped in either their GTP- or GDP-
bound forms have also been found to inhibit wild-type
function in this system (Palacios et al., 1996), and in
these cases the inhibition may be attributed to the
ability of these mutants to bind, trap, and block the
function of known import factors. For example, a non-
hydrolyzable RanzGTP could block RanBP2/Nup358,
karyopherin b, or RanBP1 function, a Ran trapped in
its GDP-bound form might sequester p10, and a Ran
unable to exchange GTP for GDP could block the
nucleotide exchange activity of the system (Dasso et
al., 1994; Klebe et al., 1995; Rush et al., 1996). The
properties of purified E1-Ran in vitro suggest that it
might be trapped in a GTP-bound state (Figure 4), but
that this E1-RanzGTP should have little or no ability to
compete with wild-type Ran for known effector inter-
actions (Figures 1 and 2). This reasoning raised the
possibility that E1-Ran might either bind and trap an
additional, nondigitonin-extractable Ran-interacting
protein required for nuclear import or that E1-Ran
might inhibit Ran-stimulated protein import as a re-
sult of its ability to bind p10.
The demonstration that addition of excess p10 can
overcome E1-Ran inhibition (Figure 8) certainly sup-
ports the latter possibility. However, although the in
vitro-permeabilized cell assay has been of inestimable
value in identifying and characterizing components of
the nuclear protein import process, such as karyo-
pherins a and b and Ran, the interpretation of specific
Figure 8 (cont). import by E1-Ran. Assays were performed with (c
15 mg/ml wild-type RanzGDP, 5 mg/ml p10, and the indicated
concentrations of E1-RanzGDP. (C) Effect of increasing concentra-
tions of p10 on E1-Ran inhibition of nuclear protein import. Assays
were performed with 15 mg/ml wild-type RanzGDP in the presence
(E) or absence (f) of 30 mg/ml E1-RanzGDP and the indicated
concentrations of p10.
Figure 8. Inhibition of import by E1-Ran can be overcome by the
addition of excess p10. Assays were carried out at 21°C on perme-
abilized cells supplemented with 20 mg/ml human recombinant
karyopherin a, 25 mg/ml human recombinant karyopherin b, 1 mM
GTP, 20 mg/ml NLS-tagged, rhodamine-labeled human serum al-
bumin, and the indicated concentrations of p10 and wild-type
RanzGDP or E1-RanzGDP. Import was measured as mean nuclear
fluorescence in arbitrary units. (A) Effect of p10 on wild-type
RanzGDP- and E1-RanzGDP-mediated nuclear protein import. As-
says were performed with the indicated amounts of wild-type
RanzGDP (f, M) or E1-RanzGDP (F, E) in the presence (F, f) or
absence (E, M) of 5 mg/ml p10. (B) Inhibition of nuclear protein
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quantitative results from this system is often compli-
cated. For example, p10 is absolutely required in some
circumstances (Figure 8; Moore and Blobel, 1994b) but
appears to be only stimulatory in others (Paschal and
Gerace, 1995; Chi et al., 1996, 1997; ). Moreover, differ-
ent studies have yielded conflicting results related to
the role of Ran in snRNP import (Marshallsay et al.,
1996; Palacios et al., 1996), the requirement for a GT-
Pase in addition to Ran (Sweet and Gerace, 1996; Weis
et al., 1996), and the identity of the nucleotide- (GTP or
GDP) charged form of Ran most effective for import
stimulation (Chi et al., 1995, 1996; Melchior et al., 1995;
Go¨rlich et al., 1996). Most of these discrepancies prob-
ably reflect subtle differences in permeabilized cell
preparation and/or assay conditions. With these cau-
tions in mind, it should be noted that while the ability
of excess p10 to overcome E1-RanzGDP inhibition is
easily accommodated by current models for nuclear
protein import, E1-Ran inhibition of import may not
be due only to p10 trapping.
The fact that E1-Ran did not block docking of the
import substrate in either an isolated specific docking
assay at 4°C or in the process of inhibiting import
stimulated by wild-type Ran at 21°C (Figure 7) is
consistent with the hypothesis that only karyopherins
a and b are required for docking, and the observation
that neither of these proteins interacts with E1-Ran
(our unpublished observations; Figure 2). All of the
nuclear protein import studies presented in this
manuscript involved permeabilized cells supple-
mented with GDP-charged Ran plus excess free GTP.
Ran must bind and hydrolyze GTP for nuclear protein
import to occur in intact or permeabilized cells. How-
ever, the point in the overall import pathway at which
Ran-mediated GTP hydrolysis occurs and the function
of this hydrolysis,remain controversial (Melchior et al.,
1995; Go¨rlich et al., 1996).
Recently, another putative Ran effector mutant,
L43E, has been examined for dominant phenotypes
following expression in vivo (Carey et al., 1996). The
L43E mutant protein inhibited cell proliferation, but
appeared not to affect nuclear protein import. Whether
the properties of this mutant, at least in terms of
import inhibition, differ from those of E1-Ran or reflect
different assay conditions, such as excess p10 in vivo,
remains to be determined.
In addition to characterizing the interactions of the
E1-Ran point mutant, we have also examined the
properties of a RanGAP1 deletion mutant. None of the
sequence motifs associated with GTPase-activating
domains of the GAP proteins of other GTPases has
been identified in RanGAP1. Our demonstration that a
large carboxyl-terminal region of RanGAP1, well-con-
served between mouse and human RanGAP proteins
but absent from S. cerevisiae and S. pombe proteins, can
be deleted without a drastic loss in GAP activity (Fig-
ure 4) suggests that the GTPase-stimulating activity of
RanGAP1 will be located wholly or predominantly
within the protein’s amino terminal 358 residues. This
amino terminal region (c-del RanGAP1) contains a
series of leucine-rich repeats that may be responsible
for Ran binding, since such repeats in other proteins
define regions responsible for protein–protein interac-
tions (Kobe and Deisenhofer, 1995). The isolated car-
boxyl-terminal fragment, which lacks leucine-rich re-
peats, does not exhibit GAP activity (our unpublished
observations). It might stabilize the Ran–RanGAP in-
teraction or mediate interaction of Ran with down-
stream targets specific to mammalian systems.
The data presented here indicate that as with other
small GTPases, Ran effector mutants are valuable tools
for elucidating and confirming the mechanism(s) of
Ran function. Specifically, it will be interesting to de-
termine whether E1-Ran is defective in other biologi-
cal processes attributed to Ran and whether E1-Ran
can be used to identify additional Ran effectors.
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